Inventor
Marcie Glicksman
Inventor
Winchester, MA, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes28%
C07DHeterocyclic compounds24%
C07CAcyclic or carbocyclic compounds7%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
Y02ATechnologies for adaptation to climate change3%
C07KPeptides1%
C12NMicroorganisms or enzymes1%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
10,961,254Pyrimidine compounds and methods using the same202110,842,822Diagnosis and treatment of parkinson's disease based on identification and amelioration of liver dysfunction202010,653,676Small molecule inhibitors of USP1 deubiquitinating enzyme activity202010,406,163Compounds that enhance Atoh1 expression201910,336,768Pyrimidine compounds and methods using the same20199,556,129'Phosphatidylcholine transfer protein inhibitors'20179,518,032'Small molecule inhibitors of USP1 deubiquitinating enzyme activity'20169,447,075'Pyridazine derivatives as EAAT2 activators'20169,433,610'Compounds that enhance Atoh1 expression'20169,359,363'Identification of compounds that disperse TDP-43 inclusions'20169,212,209'Screening methods for spinal muscular atrophy'20159,126,938'Phosphatidylcholine transfer protein inhibitors'20158,927,545'Inhibiting Eph B-3 kinase'20158,859,597'Compounds that enhance Atoh1 expression'20148,188,131'Compounds that enhance Atoh1 expression'20125,756,494'Protein kinase inhibitors for treatment of neurological disorders'19985,741,808'Protein kinase inhibitors for treatmen of neurological disorders'19985,621,101'Protein kinase inhibitors for treatment of neurological disorders'19975,621,100'K-252a derivatives for treatment of neurological disorders'19975,516,772'K-252 derivatives which enhance neurotrophin-induced activity'19965,468,872'K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders'19955,461,146'Selected protein kinase inhibitors for the treatment of neurological disorders'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–1998Patents assigned to CEPHALON INC (7)· patent assignee history
1995–1998Patents assigned to KYOWA HAKKO KOGYO KK (7)· patent assignee history
1995–1998Based in Swarthmore, PA, US· patent location history
2012–2016Patents assigned to CUNY GREGORY D (7)· patent assignee history
2012–2016Patents assigned to GLICKSMAN MARCIE (7)· patent assignee history
2012–2020Based in Winchester, MA, US· patent location history
2016–2021Patents assigned to BRIGHAM & WOMENS HOSPITAL INC (8)· patent assignee history
2019–2021Based in Boston, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRIGHAM & WOMENS HOSPITAL INC | 8 | 2016–2021 |
| CEPHALON INC | 7 | 1995–1998 |
| CUNY GREGORY D | 7 | 2012–2016 |
| GLICKSMAN MARCIEself | 7 | 2012–2016 |
| KYOWA HAKKO KOGYO KK | 7 | 1995–1998 |
Locations
| Location | Patents | Span |
|---|---|---|
| Winchester, Massachusetts, US | 12 | 2012–2020 |
| Swarthmore, Pennsylvania, US | 7 | 1995–1998 |
| Boston, Massachusetts, US | 3 | 2019–2021 |